UVA researchers determined that ACE inhibitors, beta-blockers and thiazide diuretics appear particularly beneficial to patients with colorectal cancer.

University leadership has committed between $20 million and $50 million for research in environmental resilience and neuroscience this academic year. Leaders are seeking research ideas that will "move the needle" in addressing global challenges.

The Blue Ridge Poison Center, which has received more than 85 calls this year about snakebites, shares tips on how to handle them.

UVA education professor Tish Jennings shares how classroom practices that prioritize safety and community can help schools meet students' needs this year.

McIntire professor Peter Gray recently took a deep dive into a popular analytics tool that some organizational leaders are using to help them make decisions about employees returning to work.

A preventative drug has been available for more than a decade, yet public health officials estimate that fewer than 20% of people who would benefit from the drug are actually taking it.

Using a telehealth system called "ECHO," School of Education and Human Development professors Gail Lovette and Rose Nevill have come up with a way to help the caregivers of children with developmental delays.

UVA anthropologists China Scherz and Jarrett Zigon discuss the rise in overdose deaths, offering ideas for understanding this health crisis and different ways of healing.

Leidy Klotz's book, "Subtract," has much to say about why we should – and how we can – think of subtraction as a way to solve problems and improve the world.

As the new delta variant circulates around the globe, we checked in with infectious disease expert Dr. Bill Petri for answers on increased transmissibility, booster shot timelines and variant research at UVA.